On the binding of auranofin to Prdx6 and its potential role in cancer cell sensitivity to treatment

Free Radic Biol Med. 2024 Nov 1:224:346-351. doi: 10.1016/j.freeradbiomed.2024.08.042. Epub 2024 Aug 30.

Abstract

In this study, we demonstrate that ferroptosis is a component of the cell death mechanism induced by auranofin in HT-1080 cells, in contrast to the gold(III) compounds [Au(phen)Cl2]PF6 and [Au(bnpy)Cl2]. Additionally, we identify a potential role of Prdx6 in modulating the sensitivity of A-375 cells to auranofin treatment, whereas the gold(III) compounds evaluated here exhibit Prdx6-independent cytotoxicity. Finally, using mass spectrometry, we show that auranofin binds selectively to the catalytic Cys47 residue of Prdx6 in vitro under acidic conditions. No binding was observed with the C47S mutant or at neutral pH.

MeSH terms

  • Antineoplastic Agents / pharmacology
  • Auranofin* / pharmacology
  • Cell Line, Tumor
  • Ferroptosis / drug effects
  • Humans
  • Peroxiredoxin VI* / genetics
  • Peroxiredoxin VI* / metabolism
  • Protein Binding

Substances

  • Auranofin
  • Peroxiredoxin VI
  • PRDX6 protein, human
  • Antineoplastic Agents